Ibnsina Pharma’s shareholders include prominent members of the Egyptian business community — and large institutional shareholders who trust our world-class governance structures. Among our institutional shareholders:

Faisal Islamic Bank (FIB)
Established in 1979 as Egypt’s first Islamic bank, with capital of US$500 million, FIB has grown to serve a customer base of more than 1.5 million and manage assets worth over US$6 billion.

European Bank for Reconstruction and Development (EBRD)
Founded between 1989 and 1991 by a coalition of central banks from 64 countries, the EBRD’s mission is to develop open and sustainable market economies in countries committed to democratic principles of governance. Since its establishment, the EBRD has invested over €100 billion in 4,500 projects across 34 countries. The EBRD has a €30 billion capital base, and it is the largest single investor in Central and Eastern Europe and Central Asia, with a network of over 30 local offices. The EBRD has a triple-A credit rating from all three main rating agencies: Standard & Poor’s Financial Services LLC, Moody’s Investors Service and Fitch Ratings Group.